Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

SD Reed, JI Radeva, KP Weinfurt, JJV McMurray… - American heart …, 2005 - Elsevier
BACKGROUND: In a multinational clinical trial, valsartan was statistically not inferior to
captopril in reducing mortality and cardiovascular morbidity after myocardial infarction (MI) in …
被引用次数：34 相关文章

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

SD Reed, JI Radeva, KP Weinfurt, JJV McMurray… - American Heart …, 2005 - infona.pl
In a multinational clinical trial, valsartan was statistically not inferior to captopril in reducing
mortality and cardiovascular morbidity after myocardial infarction (MI) in patients with signs …
[PDF] academia.edu

[PDF][PDF] Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

academia.edu
Background In a multinational clinical trial, valsartan was statistically not inferior to captopril
in reducing mortality and cardiovascular morbidity after myocardial infarction (MI) in patients …

[引用][C] Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

SD REED, JI RADEVA, KA SCHULMAN… - The American heart …, 2005 - pascal-francis.inist.fr
Resource use, costs, and quality of life among patients in the multinational Valsartan in
Acute Myocardial Infarction Trial (VALIANT) CNRS Inist Pascal-Francis CNRS Pascal and …

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).

SD Reed, JI Radeva, KP Weinfurt… - American Heart …, 2005 - europepmc.org
Background In a multinational clinical trial, valsartan was statistically not inferior to captopril
in reducing mortality and cardiovascular morbidity after myocardial infarction (MI) in patients …

Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

SD Reed, JI Radeva, KP Weinfurt, JJV McMurray… - 2005 - pubmed.ncbi.nlm.nih.gov
Background In a multinational clinical trial, valsartan was statistically not inferior to captopril
in reducing mortality and cardiovascular morbidity after myocardial infarction (MI) in patients …

[引用][C] Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

SD Reed, JI Radeva, KP Weinfurt… - American Heart …, 2005 - eprints.gla.ac.uk
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute
Myocardial Infarction Trial (VALIANT) - Enlighten Publications Skip to main content …

[引用][C] Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

SD Reed, JI Radeva, KP Weinfurt, JJV McMurray… - American Heart …, 2005 - elibrary.ru

[引用][C] Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

SD REED, JI RADEVA, KP WEINFURT… - The American heart …, 2005 - Mosby

[引用][C] Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)

SD Reed, JI Radeva, KP Weinfurt… - The American Heart …, 2005 - Elsevier Limited